• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统检测与冠状动脉再狭窄相关的文献报道的遗传变异:GENDER 研究结果。

Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study.

机构信息

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

PLoS One. 2012;7(8):e42401. doi: 10.1371/journal.pone.0042401. Epub 2012 Aug 3.

DOI:10.1371/journal.pone.0042401
PMID:22879966
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3411750/
Abstract

BACKGROUND

Coronary restenosis after percutaneous coronary intervention still remains a significant problem, despite all medical advances. Unraveling the mechanisms leading to restenosis development remains challenging. Many studies have identified genetic markers associated with restenosis, but consistent replication of the reported markers is scarce. The aim of the current study was to analyze the joined effect of previously in literature reported candidate genes for restenosis in the GENetic DEterminants of Restenosis (GENDER) databank.

METHODOLOGY/PRINCIPAL FINDINGS: Candidate genes were selected using a MEDLINE search including the terms 'genetic polymorphism' and 'coronary restenosis'. The final set included 36 genes. Subsequently, all single nucleotide polymorphisms (SNPs) in the genomic region of these genes were analyzed in GENDER using set-based analysis in PLINK. The GENDER databank contains genotypic data of 2,571,586 SNPs of 295 cases with restenosis and 571 matched controls. The set, including all 36 literature reported genes, was, indeed, significantly associated with restenosis, p = 0.024 in the GENDER study. Subsequent analyses of the individual genes demonstrated that the observed association of the complete set was determined by 6 of the 36 genes.

CONCLUSION

Despite overt inconsistencies in literature, with regard to individual candidate gene studies, this is the first study demonstrating that the joint effect of all these genes together, indeed, is associated with restenosis.

摘要

背景

尽管医学取得了所有进步,经皮冠状动脉介入治疗后的冠状动脉再狭窄仍然是一个重大问题。揭示导致再狭窄发展的机制仍然具有挑战性。许多研究已经确定了与再狭窄相关的遗传标记物,但报告标记物的一致性复制很少。本研究的目的是分析先前文献中报道的与再狭窄相关的候选基因在 GENetic DEterminants of Restenosis (GENDER) 数据库中的联合效应。

方法/主要发现:使用 MEDLINE 搜索,包括“遗传多态性”和“冠状动脉再狭窄”这两个术语,选择候选基因。最终的集合包括 36 个基因。随后,在 GENDER 中使用 PLINK 中的基于集合的分析分析这些基因的基因组区域中的所有单核苷酸多态性(SNP)。GENDER 数据库包含 295 例再狭窄病例和 571 例匹配对照的 2,571,586 个 SNP 的基因型数据。包括所有 36 个文献报道基因的集合确实与再狭窄显著相关,在 GENDER 研究中 p = 0.024。对个别基因的后续分析表明,观察到的整个集合的关联是由 36 个基因中的 6 个决定的。

结论

尽管在个体候选基因研究方面存在明显的不一致,但这是第一项表明所有这些基因的联合效应确实与再狭窄相关的研究。

相似文献

1
Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study.系统检测与冠状动脉再狭窄相关的文献报道的遗传变异:GENDER 研究结果。
PLoS One. 2012;7(8):e42401. doi: 10.1371/journal.pone.0042401. Epub 2012 Aug 3.
2
Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene.基于全基因组关联研究数据的冠状动脉再狭窄通路分析——PARVB 基因的潜在作用。
PLoS One. 2013 Aug 9;8(8):e70676. doi: 10.1371/journal.pone.0070676. eCollection 2013.
3
Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?基质金属蛋白酶 2 和 3 基因多态性与经皮冠状动脉介入治疗后靶血管血运重建的风险:是否仍有确定 MMP 遗传变异以评估再狭窄风险增加的空间?
Dis Markers. 2010;29(5):265-73. doi: 10.3233/DMA-2010-0757.
4
A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.一项全基因组关联研究鉴定出 12 号染色体上的一个区域可能是经皮冠状动脉介入治疗后再狭窄的易感性位点。
Hum Mol Genet. 2011 Dec 1;20(23):4748-57. doi: 10.1093/hmg/ddr389. Epub 2011 Aug 30.
5
Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.哈萨克族人群经皮冠状动脉介入治疗后再狭窄的遗传危险因素
Hum Genomics. 2016 Jun 8;10(1):15. doi: 10.1186/s40246-016-0077-z.
6
Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.Toll 样受体 4 基因多态性与经皮冠状动脉介入治疗后临床或血管造影再狭窄的风险无关。
Pharmacogenet Genomics. 2010 Sep;20(9):544-52. doi: 10.1097/FPC.0b013e32833d7b29.
7
Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.基因炎症因子可预测经皮冠状动脉介入治疗后的再狭窄。
Circulation. 2005 Oct 18;112(16):2417-25. doi: 10.1161/CIRCULATIONAHA.105.536268.
8
ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.ALOX5AP 变体与经皮冠状动脉介入治疗后的支架内再狭窄有关。
Atherosclerosis. 2008 Nov;201(1):148-54. doi: 10.1016/j.atherosclerosis.2008.01.011. Epub 2008 Feb 12.
9
Rationale and study design of the CardioGene Study: genomics of in-stent restenosis.心脏基因研究的基本原理与研究设计:支架内再狭窄的基因组学
Pharmacogenomics. 2004 Oct;5(7):952-1004. doi: 10.1517/14622416.5.7.949.
10
Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis.血红素加氧酶-1基因启动子多态性与冠心病及经皮冠状动脉介入治疗后的再狭窄相关:一项荟萃分析。
Oncotarget. 2016 Dec 13;7(50):83437-83450. doi: 10.18632/oncotarget.13118.

引用本文的文献

1
Vascular Endothelial Growth Factor Genetic Variant Is Associated with in-Stent Restenosis after Percutaneous Coronary Intervention.血管内皮生长因子基因变异与经皮冠状动脉介入治疗后的支架内再狭窄相关。
J Tehran Heart Cent. 2022 Jul;17(3):119-126. doi: 10.18502/jthc.v17i3.10844.
2
Genetic Variants in PHACTR1 & LPL Mediate Restenosis Risk in Coronary Artery Patients.PHACTR1 和 LPL 基因变异与冠状动脉患者再狭窄风险相关。
Vasc Health Risk Manag. 2023 Feb 16;19:83-92. doi: 10.2147/VHRM.S394695. eCollection 2023.
3
Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents.

本文引用的文献

1
Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension.维生素D受体(VDR)基因FokI多态性对原发性高血压的风险。
Indian J Hum Genet. 2011 Sep;17(3):201-6. doi: 10.4103/0971-6866.92104.
2
Genomics of cardiovascular disease.心血管疾病的基因组学
N Engl J Med. 2011 Dec 1;365(22):2098-109. doi: 10.1056/NEJMra1105239.
3
Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways.对人类长寿的全基因组关联研究(GWAS)数据进行基因集分析,突出了胰岛素/胰岛素样生长因子-1信号传导和端粒维持途径的相关性。
第二代和第三代药物洗脱支架支架内再狭窄的遗传风险模型
iScience. 2021 Sep 3;24(9):103082. doi: 10.1016/j.isci.2021.103082. eCollection 2021 Sep 24.
4
Association of -3 rs1053004 and rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients.-3 rs1053004和rs11574077与转移性结直肠癌患者中FOLFIRI相关胃肠道毒性的关联
Front Pharmacol. 2018 Apr 13;9:367. doi: 10.3389/fphar.2018.00367. eCollection 2018.
5
Treatment of coronary in-stent restenosis: a systematic review.冠状动脉支架内再狭窄的治疗:一项系统评价
J Geriatr Cardiol. 2018 Feb;15(2):173-184. doi: 10.11909/j.issn.1671-5411.2018.02.007.
6
Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.裸金属支架冠状动脉介入治疗后VEGF基因多态性与支架内再狭窄的关联
Dis Markers. 2017;2017:9548612. doi: 10.1155/2017/9548612. Epub 2017 Mar 7.
7
Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.哈萨克族人群经皮冠状动脉介入治疗后再狭窄的遗传危险因素
Hum Genomics. 2016 Jun 8;10(1):15. doi: 10.1186/s40246-016-0077-z.
8
Genetics of coronary artery disease and myocardial infarction.冠状动脉疾病和心肌梗死的遗传学
World J Cardiol. 2016 Jan 26;8(1):1-23. doi: 10.4330/wjc.v8.i1.1.
9
The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.丁酰胆碱酯酶(BCHE)基因的rs1803274多态性与冠状动脉支架内再狭窄风险增加相关。
BMC Cardiovasc Disord. 2015 Oct 24;15:135. doi: 10.1186/s12872-015-0128-8.
10
Genetic variation in genes encoding airway epithelial potassium channels is associated with chronic rhinosinusitis in a pediatric population.编码气道上皮钾通道的基因中的遗传变异与儿科人群的慢性鼻-鼻窦炎相关。
PLoS One. 2014 Mar 3;9(3):e89329. doi: 10.1371/journal.pone.0089329. eCollection 2014.
Age (Dordr). 2013 Feb;35(1):235-49. doi: 10.1007/s11357-011-9340-3. Epub 2011 Nov 24.
4
Restenosis after PCI. Part 2: prevention and therapy.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 2 部分:预防和治疗。
Nat Rev Cardiol. 2011 Oct 11;9(2):79-90. doi: 10.1038/nrcardio.2011.148.
5
Comparisons of seven algorithms for pathway analysis using the WTCCC Crohn's Disease dataset.使用WTCCC克罗恩病数据集对七种通路分析算法的比较。
BMC Res Notes. 2011 Oct 7;4:386. doi: 10.1186/1756-0500-4-386.
6
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
7
A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention.一项全基因组关联研究鉴定出 12 号染色体上的一个区域可能是经皮冠状动脉介入治疗后再狭窄的易感性位点。
Hum Mol Genet. 2011 Dec 1;20(23):4748-57. doi: 10.1093/hmg/ddr389. Epub 2011 Aug 30.
8
Gene set analysis of SNP data: benefits, challenges, and future directions.基于 SNP 数据的基因集分析:优势、挑战与未来方向
Eur J Hum Genet. 2011 Aug;19(8):837-43. doi: 10.1038/ejhg.2011.57. Epub 2011 Apr 13.
9
Polymorphisms of antioxidant enzymes, blood pressure and risk of hypertension.抗氧化酶的多态性、血压与高血压的风险。
J Hypertens. 2011 Mar;29(3):492-500. doi: 10.1097/HJH.0b013e328341f1b2.
10
Multi-locus test conditional on confirmed effects leads to increased power in genome-wide association studies.多基因座条件检验导致全基因组关联研究的功效增加。
PLoS One. 2010 Nov 16;5(11):e15006. doi: 10.1371/journal.pone.0015006.